Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-02

Clinical Trial Update: Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus [Phase 2]

View source ↗

Summary

A Phase 2 trial update on the biological standardization of allergen extracts from Betula pendula pollen, Phleum pratense pollen, and Dermatophagoides pteronyss…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betula pendula pollen extract (Betula pendula pollen extract)
  • Dermatophagoides pteronyssinus mite extract (Dermatophagoides pteronyssinus mite extract)
  • Phleum pratense pollen extract (Phleum pratense pollen extract)

Snippet

Sponsor: Roxall Medicina España S.A | Conditions: Allergy | Phase 2 | Status: COMPLETED